Skip to content
About
Clinical Trials
Resources
Contact
Menu
About
Clinical Trials
Resources
Contact
BrUOG 428
Targeting Androgen Receptor in bladder cancer. A Pilot Study of Degarelix in Combination with Neoadjuvant Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer.
Status:
Open
Trial Type:
Kidney and Bladder Cancer
Contact:
Sheldon Holder, MD, PhD
Sheldon_holder@brown.edu
